Inventor · disambiguated record
Michael Scott Wilson
Also filed as: WILSON MICHAEL SCOTT
15 granted patents·5 pending applications·75 citations·filing 2013–2021
91Inventor score
Top patents by PatentIndex Score
20 records- 0195US8952169B2N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2013·Granted Feb 10, 2015·25 cites·43 claims
- 0292US9694002B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Granted Jul 4, 2017·11 cites·10 claims
- 0392US9546164B2Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2015·Granted Jan 17, 2017·13 cites·38 claims
- 0490US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 0589US10745392B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 18, 2020·4 cites·47 claims
- 0687US10005724B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2015·Granted Jun 26, 2018·6 cites·11 claims
- 0783US11325902B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·1 cites·33 claims
- 0883US9550775B2Substituted triazolopyridines and methods of use thereofGENENTECH INC·Filed 2014·Granted Jan 24, 2017·7 cites·26 claims
- 0982US10981905B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted Apr 20, 2021·1 cites·54 claims
- 1081US10125098B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Nov 13, 2018·2 cites·12 claims
- 1176US10526285B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2018·Granted Jan 7, 2020·1 cites·17 claims
- 1275US10752623B2Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitorsXENON PHARMACEUTICALS INC·Filed 2019·Granted Aug 25, 2020·1 cites·38 claims
- 1371US10457654B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2017·Granted Oct 29, 2019·1 cites·19 claims
- 1470US11149002B2Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 19, 2021·0 cites·13 claims
- 1569US2021093618A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1667US2020108054A1Substituted benzamides and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 1764US11639351B2Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2021·Granted May 2, 2023·0 cites·18 claims
- 1856US2017002017A1N-substituted benzamides and methods of use thereofGENENTECH INC·Filed 2016·Application pending·0 cites
- 1952US2020115354A1Therapeutic compounds and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2047US2018162868A1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →